Advertisement
Screener

Collegium Pharmaceutical, Inc. (COLL) Increase (Decrease) in Accounts Payable

2.8 / 5 stars · 68/120 Roast Me

Collegium Pharmaceutical, Inc. Increase (Decrease) in Accounts Payable

Collegium Pharmaceutical, Inc. (COLL) reported Increase (Decrease) in Accounts Payable of -$3.51 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-06

  • Collegium Pharmaceutical, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $317.00K.
  • Collegium Pharmaceutical, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$3.83M, a 127.49% decline year-over-year.
  • Collegium Pharmaceutical, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $3.04M, a 275.93% increase year-over-year.
  • Collegium Pharmaceutical, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$3.28M.
  • Collegium Pharmaceutical, Inc. increase (decrease) in accounts payable for fiscal 2025 was $6.72M.
  • Collegium Pharmaceutical, Inc. increase (decrease) in accounts payable for fiscal 2024 was -$11.28M, a 322.84% decline from fiscal 2023.
  • Collegium Pharmaceutical, Inc. increase (decrease) in accounts payable for fiscal 2023 was $5.06M.
  • Collegium Pharmaceutical, Inc. increase (decrease) in accounts payable for fiscal 2022 was -$707.00K.
Period endIncrease (Decrease) in Accounts Payable 3 monthIncrease (Decrease) in Accounts Payable 6 monthIncrease (Decrease) in Accounts Payable 9 monthIncrease (Decrease) in Accounts Payable 12 month
2026-06-30$317.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$3.51M
10-Q · filed 2026-08-06
-$465.00K
derived: sum of 3 quarters · filed 2026-08-06
-$3.75M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31-$3.83M
10-Q · filed 2026-05-07
-$782.00K
derived: sum of 2 quarters · filed 2026-05-07
-$4.07M
derived: sum of 3 quarters · filed 2026-05-07
-$11.03M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$3.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$238.00K
derived: sum of 2 quarters · filed 2026-02-26
-$7.20M
derived: sum of 3 quarters · filed 2026-08-06
$6.72M
10-K · filed 2026-02-26
2025-09-30-$3.28M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
-$10.25M
derived: sum of 2 quarters · filed 2026-08-06
$3.67M
10-Q · filed 2025-11-06
$4.48M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30-$6.96M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$6.96M
10-Q · filed 2026-08-06
$7.77M
derived: sum of 3 quarters · filed 2026-08-06
$1.82M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$13.92M
10-Q · filed 2026-05-07
$14.73M
derived: sum of 2 quarters · filed 2026-05-07
$8.79M
derived: sum of 3 quarters · filed 2026-05-07
$5.18M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$810.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$5.13M
derived: sum of 2 quarters · filed 2026-02-26
-$8.74M
derived: sum of 3 quarters · filed 2026-02-26
-$11.28M
10-K · filed 2026-02-26
2024-09-30-$5.94M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
-$9.55M
derived: sum of 2 quarters · filed 2025-11-06
-$12.09M
10-Q · filed 2025-11-06
-$7.13M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30-$3.61M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
-$6.14M
10-Q · filed 2025-08-07
-$1.19M
derived: sum of 3 quarters · filed 2026-02-26
-$8.00K
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31-$2.54M
10-Q · filed 2025-05-08
$2.42M
derived: sum of 2 quarters · filed 2026-02-26
$3.60M
derived: sum of 3 quarters · filed 2026-02-26
$3.03M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$4.96M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$6.14M
derived: sum of 2 quarters · filed 2026-02-26
$5.56M
derived: sum of 3 quarters · filed 2026-02-26
$5.06M
10-K · filed 2026-02-26
2023-09-30$1.18M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
$608.00K
derived: sum of 2 quarters · filed 2024-11-07
$106.00K
10-Q · filed 2024-11-07
-$4.04M
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30-$573.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$1.07M
10-Q · filed 2024-08-08
-$5.22M
derived: sum of 3 quarters · filed 2025-02-27
-$4.21M
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31-$502.00K
10-Q · filed 2024-05-09
-$4.64M
derived: sum of 2 quarters · filed 2025-02-27
-$3.63M
derived: sum of 3 quarters · filed 2025-02-27
-$859.00K
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31-$4.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
-$3.13M
derived: sum of 2 quarters · filed 2025-02-27
-$357.00K
derived: sum of 3 quarters · filed 2025-02-27
-$707.00K
10-K · filed 2025-02-27
2022-09-30$1.01M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
$3.79M
derived: sum of 2 quarters · filed 2023-11-07
$3.44M
10-Q · filed 2023-11-07
-$105.00K
derived: sum of 4 quarters · filed 2024-02-22
2022-06-30$2.78M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03
$2.43M
10-Q · filed 2023-08-03
-$1.11M
derived: sum of 3 quarters · filed 2024-02-22
-$929.00K
derived: sum of 4 quarters · filed 2024-02-22
2022-03-31-$350.00K
10-Q · filed 2023-05-04
-$3.89M
derived: sum of 2 quarters · filed 2024-02-22
-$3.71M
derived: sum of 3 quarters · filed 2024-02-22
-$4.83M
derived: sum of 4 quarters · filed 2024-02-22
2021-12-31-$3.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
-$3.35M
derived: sum of 2 quarters · filed 2024-02-22
-$4.48M
derived: sum of 3 quarters · filed 2024-02-22
-$5.83M
10-K · filed 2024-02-22
2021-09-30$186.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
-$936.00K
derived: sum of 2 quarters · filed 2022-11-03
-$2.29M
10-Q · filed 2022-11-03
$1.24M
derived: sum of 4 quarters · filed 2023-02-23
2021-06-30-$1.12M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
-$2.47M
10-Q · filed 2022-08-04
$1.05M
derived: sum of 3 quarters · filed 2023-02-23
-$638.00K
derived: sum of 4 quarters · filed 2023-02-23
2021-03-31-$1.35M
10-Q · filed 2022-05-10
$2.17M
derived: sum of 2 quarters · filed 2023-02-23
$484.00K
derived: sum of 3 quarters · filed 2023-02-23
$2.53M
derived: sum of 4 quarters · filed 2023-02-23
2020-12-31$3.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
$1.83M
derived: sum of 2 quarters · filed 2023-02-23
$3.88M
derived: sum of 3 quarters · filed 2023-02-23
$3.77M
10-K · filed 2023-02-23
2020-09-30-$1.69M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$352.00K
derived: sum of 2 quarters · filed 2021-11-04
$244.00K
10-Q · filed 2021-11-04
-$5.49M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30$2.04M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
$1.94M
10-Q · filed 2021-08-05
-$3.80M
derived: sum of 3 quarters · filed 2022-02-24
-$2.76M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31-$108.00K
10-Q · filed 2021-05-06
-$5.84M
derived: sum of 2 quarters · filed 2022-02-24
-$4.80M
derived: sum of 3 quarters · filed 2022-02-24
-$7.59M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31-$5.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
-$4.69M
derived: sum of 2 quarters · filed 2022-02-24
-$7.49M
derived: sum of 3 quarters · filed 2022-02-24
-$5.90M
10-K · filed 2022-02-24
2019-09-30$1.04M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
-$1.75M
derived: sum of 2 quarters · filed 2020-11-05
-$169.00K
10-Q · filed 2020-11-05
$301.00K
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30-$2.79M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
-$1.21M
10-Q · filed 2020-08-05
-$739.00K
derived: sum of 3 quarters · filed 2021-02-25
-$7.75M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31$1.58M
10-Q · filed 2020-05-07
$2.05M
derived: sum of 2 quarters · filed 2021-02-25
-$4.96M
derived: sum of 3 quarters · filed 2021-02-25
$4.40M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31$470.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
-$6.54M
derived: sum of 2 quarters · filed 2021-02-25
$2.81M
derived: sum of 3 quarters · filed 2021-02-25
$6.46M
10-K · filed 2021-02-25
2018-09-30-$7.01M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06
$2.34M
derived: sum of 2 quarters · filed 2019-11-06
$6.00M
10-Q · filed 2019-11-06
$6.70M
derived: sum of 4 quarters · filed 2020-02-27
2018-06-30$9.36M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
$13.01M
10-Q · filed 2019-08-07
$13.71M
derived: sum of 3 quarters · filed 2020-02-27
$13.08M
derived: sum of 4 quarters · filed 2020-02-27
2018-03-31$3.65M
10-Q · filed 2019-05-08
$4.35M
derived: sum of 2 quarters · filed 2020-02-27
$3.72M
derived: sum of 3 quarters · filed 2020-02-27
$2.54M
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31$702.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$72.00K
derived: sum of 2 quarters · filed 2020-02-27
-$1.11M
derived: sum of 3 quarters · filed 2020-02-27
-$3.42M
10-K · filed 2020-02-27
2017-09-30-$630.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
-$1.81M
derived: sum of 2 quarters · filed 2018-11-08
-$4.12M
10-Q · filed 2018-11-08
-$3.96M
derived: sum of 4 quarters · filed 2019-02-27
2017-06-30-$1.18M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08
-$3.49M
10-Q · filed 2018-08-08
-$3.33M
derived: sum of 3 quarters · filed 2019-02-27
-$462.00K
derived: sum of 4 quarters · filed 2019-02-27
2017-03-31-$2.31M
10-Q · filed 2018-05-09
-$2.15M
derived: sum of 2 quarters · filed 2019-02-27
$719.00K
derived: sum of 3 quarters · filed 2019-02-27
$605.00K
derived: sum of 4 quarters · filed 2019-02-27
2016-12-31$168.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27
$3.03M
derived: sum of 2 quarters · filed 2019-02-27
$2.92M
derived: sum of 3 quarters · filed 2019-02-27
$5.57M
10-K · filed 2019-02-27
2016-09-30$2.86M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08
$2.75M
derived: sum of 2 quarters · filed 2017-11-08
$5.40M
10-Q · filed 2017-11-08
$5.74M
derived: sum of 4 quarters · filed 2018-03-07
2016-06-30-$114.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
$2.54M
10-Q · filed 2017-08-09
$2.87M
derived: sum of 3 quarters · filed 2018-03-07
$3.80M
derived: sum of 4 quarters · filed 2018-03-07
2016-03-31$2.65M
10-Q · filed 2017-05-10
$2.99M
derived: sum of 2 quarters · filed 2018-03-07
$3.92M
derived: sum of 3 quarters · filed 2018-03-07
$3.98M
derived: sum of 4 quarters · filed 2018-03-07
2015-12-31$336.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07
$1.27M
derived: sum of 2 quarters · filed 2018-03-07
$1.33M
derived: sum of 3 quarters · filed 2018-03-07
$1.30M
10-K · filed 2018-03-07
2015-09-30$930.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10
$990.00K
derived: sum of 2 quarters · filed 2016-11-10
$962.00K
10-Q · filed 2016-11-10
$389.00K
derived: sum of 4 quarters · filed 2017-03-10
2015-06-30$60.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11
$32.00K
10-Q · filed 2016-08-11
-$541.00K
derived: sum of 3 quarters · filed 2017-03-10
$10.00K
derived: sum of 4 quarters · filed 2017-03-10
2015-03-31-$28.00K
10-Q · filed 2016-05-11
-$601.00K
derived: sum of 2 quarters · filed 2017-03-10
-$50.00K
derived: sum of 3 quarters · filed 2017-03-10
$1.02M
derived: sum of 4 quarters · filed 2017-03-10
2014-12-31-$573.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10
-$22.00K
derived: sum of 2 quarters · filed 2017-03-10
$1.05M
derived: sum of 3 quarters · filed 2017-03-10
$990.00K
10-K · filed 2017-03-10
2014-09-30$551.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12
$1.62M
derived: sum of 2 quarters · filed 2015-11-12
$1.56M
10-Q · filed 2015-11-12
2014-06-30$1.07M
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2015-08-12
$1.01M
10-Q · filed 2015-08-12
2014-03-31-$56.00K
10-Q/A · filed 2015-07-17
2013-12-31-$822.00K
10-K · filed 2016-03-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
Faeth Therapeutics, Inc. (FTH)United States$0.750B
Design Therapeutics, Inc. (DSGN)United States$0.766B-12.78
Verastem, Inc. (VSTM)United States$0.706B-1.71
Nuvectis Pharma, Inc. (NVCT)United States$0.705B-17.53
IRONWOOD PHARMACEUTICALS INC (IRWD)United States$0.694B5.37
Wave Life Sciences, Inc. (WVE)$0.780B-5.56
Olema Pharmaceuticals, Inc. (OLMA)United States$0.790B-5.35
Climb Bio, Inc. (CLYM)United States$0.683B-13.03
Aclaris Therapeutics, Inc. (ACRS)United States$0.792B-9.78
GERON CORP (GERN)United States$0.803B-12.14